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Abstract
Background: Chronic obstructive pulmonary disease is associated with a chronic inflammatory
response of the host to chronic exposure to inhaled toxic gases and particles. Although
inflammatory cells of both the innate and adaptive immune system infiltrate the lungs in pulmonary
emphysema and form lymphoid follicles around the small airways, the exact role of the acquired
immune system in the pathogenesis of emphysema is not known.
Methods: In this study, wild type Balb/c mice and immunodeficient scid mice – which lack functional
B- and T-cells – were exposed to mainstream cigarette smoke (CS) for 5 weeks or 6 months.
Results: Subacute CS-exposure for 5 weeks significantly increased innate inflammatory cells
(neutrophils, macrophages and dendritic cells) in the bronchoalveolar lavage (BAL) fluid of wild type
mice and scid mice, which correlated with the CS-induced upregulation of the chemokines
Monocyte Chemotactic Protein-1, Macrophage Inflammatory Protein-3α and KC (= mouse
Interleukin-8). Chronic CS-exposure for 6 months significantly increased the number of
neutrophils, macrophages, dendritic cells, CD4+ and CD8+ T-lymphocytes in BAL fluid and lungs of
wild type mice compared to air-exposed littermates, and augmented the size and number of
peribronchial lymphoid follicles. In contrast, neither B-lymphocytes, nor T-lymphocytes, nor
lymphoid follicles could be discerned in the lungs of air- or CS-exposed scid mice. Importantly,
chronic CS-exposure induced pulmonary emphysema in both wild type animals and scid mice, as
evidenced by a significant increase in the mean linear intercept and the destructive index of CS-
exposed versus air-exposed animals. The CS-induced emphysema was associated with increased
mRNA expression of matrix metalloproteinase-12 in the lungs and increased protein levels of
Tumor Necrosis Factor-α in the BAL fluid of CS-exposed Balb/c and scid mice compared to air-
exposed littermates.
Conclusion: This study suggests that the adaptive immune system is not required per se to
develop pulmonary emphysema in response to chronic CS-exposure, since emphysema can be
induced in scid mice, which lack lymphoid follicles as well as functional B- and T-cells.
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Chronic obstructive pulmonary disease (COPD) is cur-
rently listed as the fifth leading cause of death in the
world, and is also an important cause of chronic disability
and permanent impairment, representing a major eco-
nomic and social burden worldwide [1,2]. COPD is
defined by the Global Initiative for chronic Obstructive
Lung Disease (GOLD) as "a disease state characterized by
airflow limitation that is not fully reversible, and that is
usually both progressive and associated with an abnormal
inflammatory response of the lungs to noxious particles
or gases" [3]. Cigarette smoking is by far the most impor-
tant risk factor for COPD. However, only a susceptible
minority (± 15–20%) of tobacco smokers develops clini-
cally significant COPD, suggesting that genetic factors
(such as the rare hereditary deficiency of α1-antitrypsin)
must modify each individual's risk. Therefore, although
the major environmental risk factor for COPD – tobacco
smoke – is well known since many years, the cellular and
molecular mechanisms that are involved in the pathogen-
esis of COPD have not yet been fully elucidated.
In COPD, there is a chronic inflammation of the small air-
ways and the lung parenchyma, leading to fixed narrow-
ing of small airways and alveolar wall destruction
(emphysema) [4]. Multiple studies of lung specimens,
bronchial biopsies and bronchoalveolar lavage fluid of
patients with COPD have demonstrated that this chronic
inflammation is characterized by increased numbers of
alveolar macrophages, neutrophils and lymphocytes [5].
Especially CD8+ T-lymphocytes are increased in the
peripheral airways and lungs of smokers with COPD as
compared with asymptomatic smokers with normal lung
function [6,7]. Moreover, the extent of emphysema in
smokers has been related to the number of CD3+ T-cells in
the alveolar wall, and CD8+ T-lymphocytes appeared to be
the predominant cells in the alveolar wall of emphysema-
tous lungs [8,9]. One of the important functions of CD8+
T-cells is their cytolytic activity, inducing cell death by per-
forin mediated lysis and apoptosis by caspase activation
[10]. These data suggest an important role of CD8+ T-lym-
phocytes in the pathogenesis of COPD and emphysema.
Recently, Hogg et al. further characterized the nature of
the small airway obstruction in patients with COPD of
increasing severity [11]. Progression of COPD from mild
disease (GOLD stage 1) to very severe COPD (GOLD stage
4) was associated with thickening of the airway wall and
with an increased number of airways containing lym-
phocytes (not only CD8+ T-cells, but also CD4+ T-cells and
B-cells). Interestingly, these T- and B-lymphocytes are not
only increased in numbers, but are also organized into
follicles, especially in patients with severe (GOLD stage 3)
and very severe (GOLD stage 4) COPD [11]. These data
suggest that an adaptive immune response develops in
COPD patients, but it is not known whether this response
is elicited by the toxic particles and gases present in ciga-
rette smoke, or develops in relation to the microbial colo-
nization and infection known to occur in the later stages
of COPD. Moreover, it is not known whether the adaptive
immune response (including CD8+ T-cells and B-cells) is
required for the development of pulmonary emphysema.
Recently, we characterized the time course of cigarette
smoke-induced pulmonary inflammation in a murine
model of COPD [12]. In the present paper, we report the
effects of subacute (5 weeks) or chronic (24 weeks) expo-
sure to cigarette smoke in severe combined immunodefi-
ciency (scid) mice, which lack functional T-and B-cells, but
exhibit normal differentiation and function of myeloid
cells, antigen presenting cells and natural killer cells
[13,14]. We analysed the inflammatory responses in both
the bronchoalveolar lavage (BAL) and pulmonary com-
partment, and we performed morphometric analysis to
quantify the extent of emphysema in scid mice and wild
type animals, exposed to cigarette smoke or control air for
6 months.
Methods
Animals
Homozygous male Fox Chase C.B17-scid mice (8 weeks of
age) were obtained from M&B ((Møllegaard and Bom-
holtgård Breeding and Research Center A/S, Ry, Den-
mark). Wild type Balb/c mice were used as control mice, as
suggested by M&B. All mice were housed in sterilized
cages with filter tops and received sterilized food and
water ad libitum. The local Ethics Committee for animal
experimentation of Ghent University (Ghent, Belgium)
approved all in vivo manipulations.
Smoke exposure
Mice (n = 8 per group) were exposed to cigarette smoke
(CS), as described previously [12]. Briefly, groups of 8
mice were exposed to the tobacco smoke of 5 cigarettes
(Reference Cigarette 2R4F without filter, University of
Kentucky, Lexington, KY) four times a day with 30 min-
utes smoke-free intervals, 5 days a week for 5 and 24
weeks (1 and 6 months). During the first week of the
experiment, mice were exposed to the smoke of only one
cigarette a day to acclimatize them to the higher dose dur-
ing the second week. The smoke:air ratio used in this
study was 1:6. The control group was exposed to air. Car-
boxyhemoglobin levels in serum of smoke-exposed mice
was 8.3 ± 1.4 % vs 1.0 ± 0.2 % in air-exposed mice (n = 7).
Bronchoalveolar lavage (BAL)
24 hours after the last smoke exposure mice were weighed
and sacrificed with an overdose of pentobarbital (Sanofi,
Libourne, France) and a tracheal cannula was inserted. 1
ml of Hank's balanced salt solution (HBSS), free of ion-
ized calcium and magnesium but supplemented with 0.05Page 2 of 13
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cannula and recovered by gentle manual aspiration. The 4
lavage fractions were centrifuged, the cell pellet was
washed twice and finally resuspended in 1 ml of HBSS. A
total cell count was performed in a Bürcker chamber and
the differential cell counts (on at least 400 cells) were per-
formed on cytocentrifuged preparations using standard
morphologic criteria after May-Grünwald-Giemsa stain-
ing. Flow cytometric analysis of BAL-cells was also per-
formed.
Preparation of lung single cell suspensions
Following BAL, the pulmonary and systemic circulation
was rinsed. The left lung was used for histology, the right
lung for the preparation of a cell suspension as detailed
previously [15]. Briefly, the lung was thoroughly minced,
digested, subjected to red blood cell lysis, passed through
a 50 µm cell strainer, and kept on ice until labelling. Cell
counting was performed with a Z2 Beckman-Coulter par-
ticle counter (Beckman-Coulter, Ghent, Belgium).
Labelling of BAL-cells and lung single cell suspensions for 
flow cytometry
Cells were pre-incubated with Fc-receptor blocking anti-
body (anti-CD16/CD32, clone 2.4G2) to reduce non-spe-
cific binding. Monoclonal antibodies used to identify
mouse DC populations were: biotinylated anti-CD11c
(N418) and phycoerythrin (PE)-conjugated anti-I-Ek (14-
4-4S). The following antibodies were used to stain mouse
T-cell subpopulations: fluorescein isothiocyanate (FITC)-
conjugated anti-CD4 (L3T4), FITC-conjugated anti-CD8
(Ly-2), and biotinylated anti-CD3 (145-2C11) mono-
clonal antibodies. The additional marker used for activa-
tion was PE-conjugated anti-CD69 (H1.2F3). Antibodies
used to characterize B-lymphocytes were: PE-conjugated
anti-CD19 (1D3) together with anti-CD11c. Biotinylated
anti-CD11c and anti-CD3 were revealed by incubation
with streptavidine-allophycocyanine (SAv-APC). All mon-
oclonal antibodies were obtained from BD Pharmingen
(Erembodegem, Belgium), except anti-CD11c (N418
hybridoma, a gift from Prof. M. Moser, Brussels Free Uni-
versity, Belgium).
As a last step before analysis, cells were incubated with 7-
amino-actinomycin (7-AAD or viaprobe, BD Pharmin-
gen) for dead cell exclusion. All labelling reactions were
performed on ice in FACS-EDTA buffer.
Flow cytometry data acquisition was performed on a dual-
laser FACS Vantage™ flow cytometer running CELLQuest™
software (Becton Dickinson, Mountain View, California).
FlowJo software http://www.Treestar.com was used for
data analysis.
Histology
The left lung was fixated by gentle infusion of fixative (4%
paraformaldehyde) through the tracheal cannula [12].
After excision, the lung was immersed in fresh fixative dur-
ing 2 h. The lung lobe was embedded in paraffin and cut
in 3 µm transversal sections. Lung tissue samples were
stained with hematoxylin and eosin, and examined by
light microscopy for histological sections. For each ani-
mal, 10 fields at a magnification of 200× were captured
randomly from the 4 different zones of the left lung
(upper, middle upper, middle basal and basal zone) by
lab technicians using a Zeiss KS400 image analyzer plat-
form (KS400, Zeiss, Oberkochen, Germany).
Quantification of emphysema
Emphysema is a structural disorder characterized by
destruction of the alveolar walls and enlargement of the
alveolar spaces. We determined enlargement of alveolar
spaces by quantifying the mean linear intercept (Lm) and
destruction of alveolar walls by measuring the destructive
index (DI) in air- and CS-exposed mice (n = 7 for air-
exposed Balb/c and scid mice and CS-exposed Balb/c mice;
n = 6 for CS-exposed scid mice), as described previously
[12,16,17].
Quantification of airspace enlargement was determined
after 6 months smoke exposure by measuring the mean
linear intercept (Lm), using image analysis software
(Image J 1.33). Only sections without cutting artefacts,
compression or hilar structures (airway or blood vessel
with a diameter larger than 50 µm) were used in the anal-
ysis. The Lm was measured by placing a 100 × 100 µm grid
over each field. The total length of each line of the grid
divided by the number of alveolar intercepts gives the
average distance between alveolated surfaces, or the Lm
[16].
The destruction of alveolar walls was quantified by the
destructive index (DI) [17]. A grid with 42 points that
were at the center of hairline crosses was superimposed on
the lung field. Structures lying under these points were
classified as normal (N) or destroyed (D) alveolar and/or
duct spaces. Points falling over other structures, such as
duct walls, alveolar walls, etc. did not enter into the calcu-
lations. The DI was calculated from the formula: DI = D /
(D + N) × 100.
Two investigators – blinded to the exposure status and the
genotype of the mice – independently measured DI and
Lm (interobserver correlation of r = 0.85, p < 0.001).
Morphometric quantification of lymphoid follicles
To evaluate the presence of lymphoid follicles in lung tis-
sue after 6 months smoke exposure (n = 7 for air-exposed
Balb/c and scid mice and CS-exposed Balb/c mice; n = 6 forPage 3 of 13
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Cell differentiation in bronchoalveolar lavage fluid upon air or cigarette smoke exposureFigure 1
Cell differentiation in bronchoalveolar lavage fluid upon air or cigarette smoke exposure. Effect of cigarette 
smoke (CS) exposure for 1 month or 6 months on cell differentiation in bronchoalveolar lavage fluid (absolute numbers in BAL 
fluid) in wild type mice and scid mice (air-exposed mice: open bar, CS-exposed mice: closed bar): (A) total BAL cells, (B) neu-
trophils, (C) macrophages, (D) dendritic cells, (E) CD4+ T-cells and (F) CD8+ T-cells. Animals (n = 8) were exposed to 5 ciga-
rettes/group/exposure; 4 exposures/day; 5 days/week. Results are expressed as means ± SEM (** p < 0.001 versus wild type 
mice at corresponding timepoint). Numbers of total BAL cells, neutrophils, macrophages, dendritic cells, CD4+ and CD8+ T-
cells are significantly increased in CS-exposed versus air-exposed wild type mice and scid mice. No CD4+ and CD8+ T-cells 
were detected in BAL of scid mice.
Respiratory Research 2005, 6:147 http://respiratory-research.com/content/6/1/147CS-exposed scid mice), lung sections obtained from for-
malin-fixed, paraffin-embedded lung lobes were sub-
jected to the following immunohistological stainings: (A)
B220 staining and (B) CD3/B220 doublestaining. (A) Sec-
tions were stained with anti-B220-biotin (BD Pharmin-
gen) after Boehringer blocking (with triton)
(DakoCytomation, Heverlee, Belgium). Then slides were
incubated with streptavidin horseradish peroxidase and
colored with diaminobenzidine (DAB) (both obtained
from DakoCytomation). (B) At first, sections were incu-
bated with Boehringer blocking reagent with triton and
primary antibody anti-CD3, followed by goat-anti-rabbit
biotin (both obtained from DakoCytomation). Then,
slides were incubated with streptavidin horseradish per-
oxidase and colored with DAB. In a second step, sections
were stained with anti-B220-biotin after Boehringer
blocking (with triton). Finally, slides were incubated with
streptavidin alkaline phosphatase (DakoCytomation)
and colored with Vector blue (Vector Laboratories, Inc.,
Burlingame, CA). Lymphoid follicles were counted in the
tissue area surrounding the airways (airway perimeter 0–
2000 µm). Results were expressed as counts relative to the
numbers of airways per lung section.
Measurement of immunoglobulins (Ig)
After 1 and 6 months CS-exposure, IgG and IgM concen-
trations in serum were determined using a commercially
available ELISA kit (R&D Systems Europe, Abingdon,
UK).
Measurement of cytokines and chemokines
After 6 months CS-exposure, Macrophage Inflammatory
Protein-3α (MIP-3α) and KC (mouse IL-8) protein levels
were determined in BAL-fluid using commercially availa-
ble ELISA kits (R&D Systems Europe, Abingdon, UK).
After 6 months CS-exposure, Interleukin-6 (IL-6), Inter-
leukin-10 (IL-10), Monocyte Chemotactic Protein-1
(MCP-1), Interferon-γ (IFN-γ), Tumor Necrosis Factor-α
(TNF-α) and Interleukin-12 (IL-12p70) in BAL-fluid were
determined by FACS using the Cytometric Bead Array
(CBA – Mouse inflammation kit; BD Biosciences, San
Diego, CA, USA), following the manufacturers instruc-
tions. A mixture of 6 capture bead populations, each with
distinct fluorescence intensities and coated with antibod-
ies specific for IL-6, IL-10, MCP-1, IFN-γ, TNF-α and IL-
12p70, were prepared. The CBA capture beads were incu-
bated together with PE-conjugated detection antibodies,
test samples or standards, to form sandwich complexes.
Following acquisition of sample data using the flow
cytometer (FACSCalibur™ flow cytometer, BD Bio-
sciences), the sample results were generated in graphical
and tabular format using the CBA Analysis Software (BD
Biosciences, San Diego, CA, USA).
Semiquantitative RT-PCR analysis
Total lung RNA was extracted using the RNeasy Midi kit
(Qiagen, Hilden, Germany), with an additional DNAse-
step. Reverse transcription was performed at 48°C for 30
min followed by 12 min incubation at 95°C for denatur-
ation of RNA-DNA heteroduplexes, and a DNA-amplifica-
tion with 50 cycles of 95°C for 15 sec and 60°C for 1 min.
RT-PCR was performed starting from 10 ng of total RNA,
using an ABI PRISM 7700 Sequence Detection System
(Applied Biosystems, USA). After 1 month CS-exposure,
expression of matrix metalloproteinase-12 (MMP-12)
mRNA, perforin mRNA, granzyme B mRNA and Macro-
phage Inflammatory Protein-3α (MIP-3α) mRNA relative
to hypoxanthine guanine phophoribosyl transferase
(hprt) mRNA, was analysed with the Assays-on-Demand™
Gene Expression Products (Applied Biosystems, USA).
Statistical analysis
Reported values are expressed as mean ± standard error of
the mean (SEM). Statistical analysis was performed with
Sigma Stat software (SPSS 11.0 Inc, Chicago, IL, USA)
using non-parametric tests (Kruskall-Wallis, Mann-Whit-
ney U). P-values under 0.05 were considered as signifi-
cant.
Results
Cigarette smoke exposure increases innate inflammatory 
cells in the bronchoalveolar lavage fluid of both wild type 
mice and scid mice
Subacute exposure to cigarette smoke (CS) for 1 month
significantly increased the absolute number of total cells,
neutrophils, macrophages and dendritic cells in the BAL
fluid of wild type animals compared to air-exposed litter-
mates (see figure 1A–D). Also after chronic CS-exposure
for 6 months, there is a significant increase in the number
of neutrophils, macrophages and dendritic cells in the
BAL compartment of wild type mice in comparison with
air-exposed littermates. In scid mice, both subacute and
chronic exposure to CS significantly increased the number
of BAL fluid neutrophils, macrophages and dendritic cells
compared to air exposure for 1 and 6 months, respectively
(figure 1A–D). Subacute CS-exposure induced a larger
increase in the absolute number of BAL cells, neutrophils
and macrophages in wild type animals compared to scid
mice (p < 0.05). On the other hand, chronic exposure to
CS induced an even larger increase in the numbers of neu-
trophils, macrophages and dendritic cells in scid mice
compared to wild type animals (p < 0.001).
Also in the lung parenchyma, chronic exposure to CS
increased significantly the number of macrophages and
dendritic cells in wild type mice and scid mice (number of
pulmonary macrophages: wild type: air = 76.75 ± 13.2 ×
104 versus CS = 152.73 ± 6.23 × 104, p = 0.002; scid: air =
53.33 ± 4.20 × 104 versus CS = 81.35 ± 3.02 × 104, p =Page 5 of 13
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T- and B-cell populations in the lungs upon air or cigarette smoke exposureFigure 2
T- and B-cell populations in the lungs upon air or cigarette smoke exposure. Effect of cigarette smoke (CS) expo-
sure for 6 months on T-cell populations in the lungs (absolute numbers in the lungs; determined by flow cytometry) in wild 
type mice and scid mice (air-exposed mice: open squares, CS-exposed mice: closed squares): (A) lung CD4+ T-lymphocytes, (B) 
lung CD8+ T-lymphocytes, (C) activated lung CD4+ T-lymphocytes, (D) activated lung CD8+ T-lymphocytes and (E) lung B-lym-
phocytes. Animals (n = 8) were exposed to 5 cigarettes/group/exposure; 4 exposures/day; 5 days/week (* p < 0.05 and ** p < 
0.001 versus air-exposed mice).
Respiratory Research 2005, 6:147 http://respiratory-research.com/content/6/1/1470.015; number of pulmonary dendritic cells: wild type: air
= 53.54 ± 1.72 × 104 versus CS = 83.14 ± 2.70 × 104, p =
0.006; scid: air = 40.80 ± 3.12 × 104 versus CS = 103.55 ±
2.10 × 104, p = 0.003).
Chronic cigarette smoke exposure increases the number of 
B- and T-lymphocytes in the lungs of wild type animals; in 
contrast, lymphocytes remain absent in the lungs of scid 
mice
In wild type animals, subacute CS-exposure for 1 month
induced a significant increase in the number of both CD4+
and CD8+ lymphocytes in BAL fluid compared to air-
exposed littermates (figure 1E and 1F). Chronic exposure
to CS for 6 months further increased the number of BAL
CD4+ and CD8+ T-lymphocytes in wild type mice. In con-
trast, neither CD4+ nor CD8+ T-lymphocytes could be
detected in the BAL fluid of scid mice after air or CS-expo-
sure for 1 and 6 months (figure 1E and 1F).
In lung digests, chronic CS-exposure significantly
increased the number of B-lymphocytes, CD4+ T-lym-
phocytes, CD8+ T-lymphocytes and activated CD8+ T-cells
in wild type mice compared to air-exposed littermates
(figure 2A–E). In air-exposed as well as CS-exposed scid
mice, no B-lymphocytes, CD4+ T-cells or CD8+ T-cells
could be detected in the lung digests by FACS analysis (fig-
ure 2A–E) or in the lung parenchyma by immunohisto-
chemistry (figure 5).
Chronic cigarette smoke exposure induces pulmonary 
emphysema in wild type mice and scid mice
Pulmonary emphysema is characterized by destruction of
the alveolar walls due to damage to the lung parenchyma,
leading to enlargement of the alveolar spaces. Therefore,
to quantify emphysematous lesions it is recommended to
evaluate both the airspace enlargement (quantified by
measurement of the mean linear intercept [Lm]) and the
destruction of the alveolar walls (quantified by measure-
ment of the destructive index [DI]). Chronic exposure to
CS clearly induced pulmonary emphysema in wild type
animals, as evidenced by a significant increase in the Lm
(air = 38.1 ± 0.1 µm versus CS = 41.6 ± 0.2 µm, p < 0.01;
figure 3A) and in the DI (air = 33.0 ± 0.4 versus CS = 43.8
± 0.5, p < 0.05; figure 3B) compared to air-exposed wild
type littermates. In scid mice, CS-exposure for 6 months
also significantly increased the Lm (air = 38.3 ± 0.2 µm ver-
sus CS = 41.4 ± 0.2 µm, p < 0.05) and the destructive index
(air = 27.7 ± 0.6 versus CS = 37.8 ± 0.8, p < 0.05) com-
pared to air exposure (figure 3A and 3B). The significant
airspace enlargement due to chronic CS-exposure in both
wild type and scid mice is clearly demonstrated on hema-
toxylin and eosin-stained lung tissue sections in figure 4.
Serum immunoglobulin levels in wild type mice and scid 
mice
Since up to 15% of scid mice may express detectable serum
immunoglobulins (Ig) as they become "leaky" upon
aging [18], we determined levels of IgG and IgM in serum
of Balb/c and scid mice. At 6 months, air- and CS-exposed
wild type animals had similar serum IgG and IgM levels
(IgG: air = 600.7 ± 65.9 µg/ml versus CS = 646.3 ± 56.5
µg/ml, N.S.; IgM: air = 146.8 ± 9.6 µg/ml versus CS =
148.0 ± 3.4 µg/ml, N.S.). At 6 months, serum IgG and IgM
levels remained below the detection limit in all scid mice,
whether exposed to air or to CS. Only one scid mouse in
the CS-exposed group appeared to be leaky, since the
serum IgG exceeded 20 µg/ml.
Chronic cigarette smoke exposure induces pulmonary 
lymphoid follicles in wild type mice, in contrast to scid 
mice
Immunohistochemistry using anti-CD3 and anti-B220
monoclonal antibodies to stain T-lymphocytes and B-
lymphocytes respectively, revealed the presence of only a
few small lymphoid follicles in the lung areas surround-
ing the airways of air-exposed wild type mice (figure 5).
Chronic CS-exposure significantly increased the number
of peribronchial lymphoid follicles in the lungs of wild
type animals (number of lymphoid follicles/airway: air:
0.10 ± 0.01 versus CS: 0.39 ± 0.02, p < 0.001). Moreover,
the density of these peribronchial lymphoid follicles was
also clearly augmented in wild type animals by CS-expo-
sure (figure 5B,E and 5F). In contrast, no lymphoid folli-
cles could be discerned in the lung parenchyma of scid
mice, which were exposed to either air or CS for 6 months
(figure 5C and 5D).
Cigarette smoke exposure increases MMP-12 mRNA in the 
lungs of wild type mice and scid mice
To elucidate the possible mechanisms by which pulmo-
nary emphysema develops in CS-exposed (scid) mice, we
measured mRNA levels of matrix metalloproteinase-12
(MMP-12), perforin and granzyme B in the lungs of air-
and CS-exposed animals by RT-PCR. CS-exposure for one
month increased the lung mRNA of MMP-12 in both wild
type and scid mice compared to air-exposed animals (p <
0.01; figure 6A). In contrast, exposure to CS did not influ-
ence the pulmonary mRNA levels of perforin and
granzyme B in wild type and scid mice (N.S.; data not
shown). Interestingly, the baseline mRNA levels for
granzyme B in the lungs of air-exposed scid mice appeared
to be higher than in air-exposed wild type mice (p < 0.01).
Since subacute CS-exposure induces increased numbers of
dendritic cells in BAL fluid and lungs of both wild type
and scid mice, we investigated the mRNA expression of
MIP-3α, which is an epithelial-derived chemokine with
specific chemoattracting properties towards immaturePage 7 of 13
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Lymphoid follicles in the lungs upon air or cigarette smoke exposureFigure 5
Lymphoid follicles in the lungs upon air or cigarette smoke exposure. Photomicrographs of lymphoid follicles in lungs 
of air- and cigarette smoke (CS)-exposed wild type mice and scid mice at 6 months (magnification × 100). (A)-(E) B220 staining 
(brown = B220 positive cells): (A) air-exposed wild type mice, (B) CS-exposed wild type mice, (C) air-exposed scid mice, (D) 
CS-exposed scid mice and (E) CS-exposed wild type mice (magnification × 200). (F) CD3/B220 staining (brown = CD3 positive 
cells; blue = B220 positive cells): CS-exposed wild type mice.
Respiratory Research 2005, 6:147 http://respiratory-research.com/content/6/1/147dendritic cells. Exposure to CS for 1 month indeed upreg-
ulated the MIP-3α mRNA expression in wild type animals
as well as scid mice (p < 0.01; figure 6B).
Cigarette smoke exposure increases protein levels of TNF-
α, MCP-1, MIP-3α and KC in bronchoalveolar lavage 
(BAL) fluid in wild type mice and scid mice
To further decipher the molecular mechanisms involved
in the pathogenesis of the CS-induced pulmonary inflam-
mation, several cytokines and chemokines were measured
in the BAL fluid by Cytometric Bead Array (TNF-α, MCP-
1, IL-10, IL-6, IL-12p70 and IFNg) and ELISA (MIP-3α and
KC). At six months, CS-exposure significantly increased
the BAL levels of TNF-α, MCP-1, MIP-3α and KC in both
scid and wild type mice compared to air-exposure (figure
7). Similar levels of TNF-α, MCP-1 and MIP-3α were
found in BAL fluid of CS-exposed wild type and scid mice,
while levels of KC in lavage of scid mice were significantly
elevated compared to wild type mice upon CS-exposure.
The levels of IL-10, IL-6 and IL-12p70 in BAL fluid were
low in all groups and did not differ between air- or CS-
exposed mice (data not shown). The levels of IFN-γ were
below the detection limit in almost all BAL fluid samples,
irrespective of mouse genotype or exposure regimen (data
not shown).
Discussion
In this study we show for the first time that chronic ciga-
rette smoke (CS)-exposure for six months (i) increases the
number of innate inflammatory cells in BAL and lungs of
both wild type and scid mice; (ii) increases the number of
peribronchial lymphoid follicles in wild type mice in con-
trast to scid mice; and, most importantly, (iii) induces pul-
monary emphysema not only in wild type animals, but
also in scid mice, despite the complete absence of B- and
T-lymphocytes in the latter.
A potential role for T-lymphocytes in the development of
pulmonary emphysema in human smokers has been sug-
gested, since cytotoxic CD8+ T-cells are increased in the
lungs of smokers and have the capacity to cause (perforin-
or granzym B-mediated) cytolysis and apoptosis (by Fas-
Fas ligand interaction or by caspase activation) of alveolar
epithelial cells [6,7,9,10,19-21]. However, the observed
correlation between increased T-lymphocytes in the alve-
olar wall of COPD patients and the extent of emphysema,
does not prove a causal relationship. Moreover, consider-
able variation in the counts of CD8+ T-cells has been
described in bronchial biopsies of smokers with chronic
bronchitis [22].
Therefore, to examine whether the adaptive immune
response, consisting of B- and T-lymphocytes, is actually
causing pulmonary emphysema in response to CS, we
investigated the effects of subacute and chronic CS-expo-
sure in wild type Balb/c mice and in scid mice, which lack
functional B- and T-cells [13,23]. Chronic CS-exposure
induced emphysema in both wild type and scid mice.
Since scid mice have a normal innate immune system,
including the epithelial barrier, monocytes/macrophages,
neutrophils and highly functional NK cells [24], these
experimental findings underline the important role of
innate immunity in the development of pulmonary
emphysema. After one month CS-exposure, scid mice had
less neutrophils and macrophages in BAL compared to
wild type animals. At six months, however, the number of
BAL neutrophils, macrophages and dendritic cells – spe-
cialized antigen presenting cells, linking the innate and
the adaptive immune system [25] – were even higher in
CS-exposed scid mice. We speculate that the higher
number of neutrophils, macrophages and dendritic cells
Quantification of pulmonary emphysema in wild type mice and scid miceFigure 3
Quantification of pulmonary emphysema in wild type 
mice and scid mice. Effect of cigarette smoke (CS) expo-
sure for 6 months on emphysema in wild type mice and scid 
mice (air-exposed mice: open squares, CS-exposed mice: 
closed squares). (A) mean linear intercept (µm) and (B) 
destructive index (* p < 0.05 and ** p < 0.01 versus air-
exposed mice).Page 9 of 13
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B- and T-lymphocytes in scid mice. Cigarette smoke may
activate lung resident cells, including epithelial cells and
macrophages, which then release inflammatory media-
tors, including cytokines (eg TNF-α and KC (mouse IL-8))
and chemokines (eg MIP-3α and MCP-1) [26-29]. We
demonstrated increased protein levels of TNF-α, KC,
MCP-1 and MIP-3α in BAL-fluid upon CS-exposure,
thereby attracting neutrophils, macrophages and dendri-
titc cells to the lungs. Inflammatory cells might contribute
to the development of pulmonary emphysema, since they
have the capacity to secrete many elastolytic enzymes,
such as neutrophil elastase (by neutrophils) and MMP-12
(by macrophages and dendritic cells). Both proteases have
been reported to be important in COPD [4,30,31].
Recently, James Hogg et al. characterized the nature of the
small airway obstruction in patients with COPD [11,32].
Interestingly, the progression of COPD was associated
with the infiltration of the airway wall by innate and
adaptive immune cells that formed lymphoid follicles
[11]. Although the cause of the appearance of lymphoid
follicles in the later stages of COPD (GOLD stage 3 and 4)
is not known, it was speculated that this adaptive immune
response develops in response to the microbial coloniza-
tion and infection known to occur in patients with severe
COPD. However, whether these lymphoid follicles are
required to develop emphysema in response to CS, is cur-
rently not known. Our experimental findings in mice
pointed out that (i) chronic CS-exposure indeed induced
peribronchial lymphoid follicles in wild type Balb/c mice,
but that (ii) pulmonary emphysema still developed even
in the absence of any lymphoid follicles, as is the case in
the scid mice. This does not exclude the possibility that the
lymphoid follicles could accelerate the decline in lung
function in COPD patients or aggravate the extent of CS-
Pulmonary emphysema in wild type versus scid mice after 6 months air or CS-exposureFigure 4
Pulmonary emphysema in wild type versus scid mice after 6 months air or CS-exposure. Photomicrographs of 
hematoxylin and eosin stained lung tissue of air- and cigarette smoke (CS)-exposed wild type mice and scid mice at 6 months 
(magnification × 200). (A) air-exposed wild type mice, (B) CS-exposed wild type mice, (C) air-exposed scid mice and (D) CS-
exposed scid mice.Page 10 of 13
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murine model of COPD, the wild type animals did not
suffer from more severe emphysema despite the presence
of lymphoid follicles.
A possible limitation of the study could be the occurrence
of "leakiness" in scid mice, which leads to the production
of some functional B- and T-cells [33]. However, after
chronic exposure to air or CS, only one scid mouse out of
13 had serum IgG levels exceeding 20 µg/ml, indicating
leakiness. Lastly, the CS-induced emphysema in scid mice
could theoretically be attributed to the presence of the
NK-cell, since an enhanced activity of these innate
immune cells has been described in these animals [24]. To
test this hypothesis, we determined the expression levels
of the 2 major cytolytic effector proteins of NK-cells,
namely perforin, a pore-forming protein, and granzyme B,
a member of the serine proteinase family [10]. We found
elevated RNA levels of granzyme B in scid mice compared
to wild type animals, but these levels of granzyme B did
not augment upon CS-exposure in both strains of mice.
Moreover, after chronic CS-exposure, the mRNA levels of
perforin did not increase in wild type and scid mice, argu-
ing indirectly against the hypothesis that the NK-cell
could drive the CS-induced emphysema in scid mice (data
not shown).
Conclusion
In this paper, we demonstrated for the first time that
chronic exposure to mainstream cigarette smoke can
induce pulmonary emphysema in scid mice, which lack
functional B- and T-cells and which lack peribronchial
lymphoid follicles. Since CS-exposure induces a progres-
sive increase in key inflammatory cells of the innate
immune system (neutrophils, macrophages and dendritic
cells) and augments several epithelium-derived chemok-
ines, these in vivo studies suggest that the innate immune
system plays a major role in the pathogenesis of COPD
and pulmonary emphysema.
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Expression of MMP-12 and MIP-3α RNA in lungs upon air or ciga tte smoke exposureFigure 6
Expression of MMP-12 and MIP-3α RNA in lungs 
upon air or cigarette smoke exposure. (A) MMP-12 and 
(B) MIP-3α RNA expression in lung tissue of wild type mice 
and scid mice to air or cigarette smoke (CS) exposure for 1 
month (air-exposed mice: open bar, CS-exposed mice: 
closed bar). RT-PCR results are expressed as a ratio target 
mRNA with hprt (hypoxanthine guanine phosphoribosyl 
transferase) mRNA (mean ± SEM, n = 5 animals per group, * 
p < 0.05 and ** p < 0.01). MMP-12: matrix metalloprotein-
ase-12; MIP-3α: Macrophage Inflammatory Protein-3α.Page 11 of 13
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